Analgesia Nociception Index monitoring of the autonomic nervous system during continuous renal replacement therapy
Official title: Analgesia Nociception Index and Autonomic Nervous System Exploration During Continuous Renal Replacement Therapy in Intensive Care Patients.
Run by Hospices Civils de Lyon · NCT06285162 · Data updated 2026-11-12
We will try using the Analgesia Nociception Index to see if changes in autonomic signals match blood pressure and heart responses when fluid is removed during continuous renal replacement therapy in critically ill adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Status | Recruiting |
| Started | January 9, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT06285162 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult ICU patients receiving continuous renal replacement therapy who are undergoing net ultrafiltration, have invasive arterial and central venous lines, are in regular sinus rhythm, are not receiving inotropes or certain chronotropic agents, and meet the department's fluid-overload criteria would be ideal candidates.
✕Probably not a fit
Patients with arrhythmias, on inotropes, beta-blockers, or alpha-2 agonists, those with known dysautonomia, pregnant or breastfeeding patients, or those lacking invasive monitoring are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational protocol that continuously records the Analgesia Nociception Index (ANI) alongside invasive hemodynamic measurements in ICU patients on continuous renal replacement therapy (CRRT) undergoing net ultrafiltration. Eligible patients have invasive arterial and central venous monitoring, regular sinus rhythm, and meet local fluid-overload and stability criteria, while patients on inotropes, beta-blockers, or with dysautonomia are excluded. ANI and standard vital signs will be captured before, during, and after fluid removal and analyzed for temporal associations with blood pressure and heart rate changes. No changes to clinical care are mandated by the protocol; data are collected from routine CRRT sessions to characterize autonomic-related hemodynamic variation.
Why it matters
Potential benefit: If successful, this could help clinicians detect autonomic-driven hemodynamic instability during fluid removal and guide safer ultrafiltration choices.
How similar studies have gone: ANI has been used to monitor autonomic tone and nociception in anesthesia and some ICU settings, but applying it specifically to hemodynamic effects during ultrafiltration in CRRT is novel and only sparsely studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Continuous renal replacement therapy in intensive care unit * Initiation of net ultrafiltration according to the protocol of the department or to EARLYDRY study (NCT 05817539) (3 criteria required): * Fluid overload \> 5% or peripheral oedema * Noradrenaline equivalent \<0.5μg/kg/min * No peripheral hypoperfusion * Invasive blood pressure monitoring * Central venous line in superior vena cava territory * Regular sinus rhythm * Patient awake or Richmond Agitation and Sedation Scale \> -3 Exclusion Criteria: * Ongoing administration of inotropes * Ongoing administration of beta blockers * Current administration of alpha-2 agonists * History of dysautonomia * Pregnant or breast-feeding woman * Mechanical circulatory assistance * Opposition to participate * Adults under legal protection * Persons deprived of their liberty by judicial or administrative decision
Where it's running
-
Département d'anesthésie-réanimation Hôpital cardiologique Louis Pradel
Bron, France Recruiting
Study contacts
- Principal investigator: Martin RUSTE, MD — Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, HCL
- Study coordinator: Martin RUSTE, MD
- Email: martin.ruste@chu-lyon.fr
- Phone: +33472118956
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FST Decision Support to Help Timely Therapy for Kids with AKI Risk
This study tests whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe AKI.
-
Transducer levelling errors in everyday ICU practice
In critically ill, vasopressor-treated adults with arterial and central venous lines, this study tests how small height differences in pressure transducers may lead to measurement errors that could affect treatment decisions.
-
Epidemiology and care for dialysis in ICU patients with severe acute kidney injury in Latin America
This project will collect and compare data on adults in ICUs across Latin America who need dialysis for severe acute kidney injury to see how they are treated and what outcomes they have.
-
What predicts death in the ICU? Analyzing APACHE II in Colombian patients
This study tests how well the APACHE II score predicts ICU mortality in adults treated at a Colombian hospital.
-
Using parasternal intercostal muscle thickening to help decide when to stop mechanical ventilation
This trial will test whether adding a bedside ultrasound measurement of parasternal intercostal muscle thickening helps doctors decide when to take critically ill patients off mechanical ventilation to reduce reintubation.
-
AI software predicting acute kidney injury in ICU patients
This study is testing whether a new AI tool can help doctors predict and prevent kidney problems in ICU patients by alerting them when someone is at high risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.